Key facts
- This page summarizes Mao Zhang's Form 4 filing for Harvard Apparatus Regenerative Technology, Inc. (HRGN).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 01 Jul 2025, 14:03.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Award
Additional SEC filing notes
Footnote F1
This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 27, 2025, December 27, 2025, March 27, 2026 and June 27, 2026.
Footnote F2
This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2025, September 30, 2025 and December 31, 2025.
SEC remarks
This form has been signed under power of attorney.